🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2750
-0.0143 (-4.94%)
At close: Nov 19, 2026, 4:00 PM EST
0.2870
+0.0120 (4.36%)
After-hours: Nov 19, 2026, 7:30 PM EST

Mereo BioPharma Group Statistics

Total Valuation

MREO has a market cap or net worth of $43.92 million. The enterprise value is $18.40 million.

Market Cap43.92M
Enterprise Value 18.40M

Important Dates

The last earnings date was Monday, November 9, 2026, before market open.

Earnings Date Nov 9, 2026
Ex-Dividend Date n/a

Share Statistics

MREO has 159.70 million shares outstanding. The number of shares has increased by 1.49% in one year.

Current Share Class n/a
Shares Outstanding 159.70M
Shares Change (YoY) +1.49%
Shares Change (QoQ) +0.12%
Owned by Insiders (%) 0.75%
Owned by Institutions (%) 16.47%
Float 122.51M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 57.26
Forward PS n/a
PB Ratio 1.95
P/TBV Ratio 1.94
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 25.36
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.22, with a Debt / Equity ratio of 0.02.

Current Ratio 5.22
Quick Ratio 4.86
Debt / Equity 0.02
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -423.14

Financial Efficiency

Return on equity (ROE) is -76.63% and return on invested capital (ROIC) is -51.94%.

Return on Equity (ROE) -76.63%
Return on Assets (ROA) -44.51%
Return on Invested Capital (ROIC) -51.94%
Return on Capital Employed (ROCE) -122.96%
Weighted Average Cost of Capital (WACC) 5.41%
Revenue Per Employee $20,513
Profits Per Employee -$690,718
Employee Count39
Asset Turnover 0.02
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -84.89% in the last 52 weeks. The beta is 0.20, so MREO's price volatility has been lower than the market average.

Beta (5Y) 0.20
52-Week Price Change -84.89%
50-Day Moving Average 0.31
200-Day Moving Average 0.32
Relative Strength Index (RSI) 41.38
Average Volume (20 Days) 735,285

Short Selling Information

The latest short interest is 3.35 million, so 2.58% of the outstanding shares have been sold short.

Short Interest 3.35M
Short Previous Month 3.23M
Short % of Shares Out 2.58%
Short % of Float n/a
Short Ratio (days to cover) 3.48

Income Statement

In the last 12 months, MREO had revenue of $800,000 and -$26.94 million in losses. Loss per share was -$0.14.

Revenue800,000
Gross Profit 800,000
Operating Income -29.62M
Pretax Income -26.94M
Net Income -26.94M
EBITDA -28.67M
EBIT -29.62M
Loss Per Share -$0.14
Full Income Statement

Balance Sheet

The company has $26.10 million in cash and $577,000 in debt, with a net cash position of $25.52 million or $0.16 per share.

Cash & Cash Equivalents 26.10M
Total Debt 577,000
Net Cash 25.52M
Net Cash Per Share $0.16
Equity (Book Value) 23.71M
Book Value Per Share 0.15
Working Capital 23.18M
Full Balance Sheet

Cash Flow

Operating Cash Flow -22.09M
Capital Expenditures n/a
Depreciation & Amortization 955,000
Net Borrowing n/a
Free Cash Flow -22.09M
FCF Per Share -$0.14
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -3,702.50%
Pretax Margin -3,367.25%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MREO does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -1.49%
Shareholder Yield -1.49%
Earnings Yield -52.00%
FCF Yield -48.22%

Analyst Forecast

The average price target for MREO is $1.95, which is 607.27% higher than the current price. The consensus rating is "Buy".

Price Target $1.95
Price Target Difference 607.27%
Analyst Consensus Buy
Analyst Count 8
Revenue Growth Forecast (3Y) 163.97%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

MREO has an Altman Z-Score of -14.9 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -14.9
Piotroski F-Score 3